Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABRAFENIB vs NILOTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABRAFENIB vs NILOTINIB: Safety Overview

Metric DABRAFENIB NILOTINIB
Total FAERS Reports 19,305 23,171
Deaths Reported 4,165 4,543
Death Rate 21.6% 19.6%
Hospitalizations 5,325 4,846
Average Patient Age 58.3 yrs 56.5 yrs
% Female Patients 48.0% 47.7%
FDA Approval Date Mar 16, 2023 Dec 15, 2025
Manufacturer Novartis Pharmaceuticals Corporation Novadoz Pharmaceuticals LLC
Route ORAL ORAL
Marketing Status Prescription Prescription